Literature DB >> 2167067

A method for the sequence analysis of dermatan sulphate.

L A Fransson1, B Havsmark, I Silverberg.   

Abstract

We are attempting to develop methods for the sequencing of glycosaminoglycans from their reducing end. Here we describe a procedure for the analysis of dermatan sulphate from pig skin. The glycosaminoglycan is released from its parent proteoglycan by exhaustive proteolysis by using both endo- and exo-peptidases. The amino group of the residual serine residue is conjugated with a p-hydroxyphenyl group, which in turn is iodinated with 125I (the Bolton-Hunter reagent, BHR). The ion-exchange-purified end-labelled dermatan sulphate is then degraded partially or completely by various enzymic or chemical means to yield fragments extending from the labelled serine residue to the point of cleavage. The various products are separated by gradient PAGE, detected by autoradiography and quantified by videodensitometry. Complete digestion with chondroitin ABC lyase affords the labelled fragment delta HexA-GalNAc(-SO4)-GlcA-Gal-Gal-Xyl-Ser(-BHR). The structure was confirmed by sequential degradation from the non-reducing end by chondroitin AC lyase, HgCl2, and beta-galactosidase. Periodate oxidation cleaves most of the Xyl even without treatment with alkaline phosphatase, showing that Xyl is not substituted with phosphate. Results from partial and selective periodate oxidation indicate that most of the non-sulphated IdoA residues are located towards the non-reducing end. Partial or complete digestions with testicular hyaluronidase (in the presence of an excess of beta-glucuronidase) or chondroitin AC lyase identify the positions of GlcA residues. The results confirm that HexA next to Gal is always GlcA. Moreover, GlcA is common in the first three disaccharide repeats. Results with testicular hyaluronidase indicate that the distribution of clustered GlcA-GalNAc repeats is periodic and peaks at positions 1-3, 8-9 and around 25. Although there must be chains that contain IdoA in nearly all of the available positions, regions that have not been fully processed during biosynthesis are markedly non-random.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2167067      PMCID: PMC1131588          DOI: 10.1042/bj2690381

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  25 in total

1.  Location of the antithrombin-binding sequence in the heparin chain.

Authors:  L G Oscarsson; G Pejler; U Lindahl
Journal:  J Biol Chem       Date:  1989-01-05       Impact factor: 5.157

2.  Location of specific oligosaccharides in heparin in terms of their distance from the protein linkage region in the native proteoglycan.

Authors:  L Rosenfeld; I Danishefsky
Journal:  J Biol Chem       Date:  1988-01-05       Impact factor: 5.157

3.  Structural determinants of heparin's growth inhibitory activity. Interdependence of oligosaccharide size and charge.

Authors:  T C Wright; J J Castellot; M Petitou; J C Lormeau; J Choay; M J Karnovsky
Journal:  J Biol Chem       Date:  1989-01-25       Impact factor: 5.157

4.  Oligosaccharide mapping of heparan sulphate by polyacrylamide-gradient-gel electrophoresis and electrotransfer to nylon membrane.

Authors:  J E Turnbull; J T Gallagher
Journal:  Biochem J       Date:  1988-04-15       Impact factor: 3.857

Review 5.  Structure and biology of proteoglycans.

Authors:  E Ruoslahti
Journal:  Annu Rev Cell Biol       Date:  1988

6.  Location on heparin of the oligosaccharide section essential for anticoagulant activity.

Authors:  S Radoff; I Danishefsky
Journal:  J Biol Chem       Date:  1984-01-10       Impact factor: 5.157

7.  Dermatan sulphate proteoglycans from sclera examined by rotary shadowing and electron microscopy.

Authors:  N P Ward; J E Scott; L Cöster
Journal:  Biochem J       Date:  1987-03-15       Impact factor: 3.857

8.  Structural studies on sulfated glycopeptides from the carbohydrate-protein linkage region of chondroitin 4-sulfate proteoglycans of swarm rat chondrosarcoma. Demonstration of the structure Gal(4-O-sulfate)beta 1-3Gal beta 1-4XYL beta 1-O-Ser.

Authors:  K Sugahara; I Yamashina; P De Waard; H Van Halbeek; J F Vliegenthart
Journal:  J Biol Chem       Date:  1988-07-25       Impact factor: 5.157

9.  Reaction of unsaturated uronic acid residues with mercuric salts. Cleavage of the hyaluronic acid disaccharide 2-acetamido-2-deoxy-3-O-(beta-D-gluco-4-enepyranosyluronic acid)-D-glucose.

Authors:  U Ludwigs; A Elgavish; J D Esko; E Meezan; L Rodén
Journal:  Biochem J       Date:  1987-08-01       Impact factor: 3.857

10.  Fractionation of heparin-derived oligosaccharides by gradient polyacrylamide-gel electrophoresis.

Authors:  K G Rice; M K Rottink; R J Linhardt
Journal:  Biochem J       Date:  1987-06-15       Impact factor: 3.857

View more
  13 in total

1.  Protective role for proteoglycans against cationic lipid cytotoxicity allowing optimal transfection efficiency in vitro.

Authors:  M Belting; P Petersson
Journal:  Biochem J       Date:  1999-09-01       Impact factor: 3.857

2.  Effects of primer-concentration on uronosyl-epimerization and sulfation patterns in p-hydroxyphenyl-O-beta-D-xylopyranoside-primed galactosaminoglycans produced by skin fibroblasts.

Authors:  F Cheng; B Havsmark; K Sakurai; H Habuchi; S Suzuki; K Yoshida; L A Fransson
Journal:  Glycoconj J       Date:  1997-02       Impact factor: 2.916

3.  Suppression of amyloid beta A11 antibody immunoreactivity by vitamin C: possible role of heparan sulfate oligosaccharides derived from glypican-1 by ascorbate-induced, nitric oxide (NO)-catalyzed degradation.

Authors:  Fang Cheng; Roberto Cappai; Giuseppe D Ciccotosto; Gabriel Svensson; Gerd Multhaup; Lars-Åke Fransson; Katrin Mani
Journal:  J Biol Chem       Date:  2011-06-03       Impact factor: 5.157

4.  Endothelial heparan sulphate: compositional analysis and comparison of chains from different proteoglycan populations.

Authors:  A Lindblom; L A Fransson
Journal:  Glycoconj J       Date:  1990       Impact factor: 2.916

5.  Binding of heparan sulfate to Staphylococcus aureus.

Authors:  O D Liang; F Ascencio; L A Fransson; T Wadström
Journal:  Infect Immun       Date:  1992-03       Impact factor: 3.441

6.  The growth promoter spermine interacts specifically with dermatan sulfate regions that are rich in L-iduronic acid and possess antiproliferative activity.

Authors:  M Belting; L A Fransson
Journal:  Glycoconj J       Date:  1993-12       Impact factor: 2.916

7.  Domain structure of endothelial heparan sulphate.

Authors:  A Lindblom; G Bengtsson-Olivecrona; L A Fransson
Journal:  Biochem J       Date:  1991-11-01       Impact factor: 3.857

8.  A tandem mass spectrometric approach to determination of chondroitin/dermatan sulfate oligosaccharide glycoforms.

Authors:  May Joy C Miller; Catherine E Costello; Anders Malmström; Joseph Zaia
Journal:  Glycobiology       Date:  2006-02-17       Impact factor: 4.313

9.  Sequence analysis of p-hydroxyphenyl-O-beta-D-xyloside initiated and radio-iodinated dermatan sulfate from skin fibroblasts.

Authors:  L A Fransson; B Havsmark; K Sakurai; S Suzuki
Journal:  Glycoconj J       Date:  1992-02       Impact factor: 2.916

10.  Sequence analysis of heparan sulphate indicates defined location of N-sulphated glucosamine and iduronate 2-sulphate residues proximal to the protein-linkage region.

Authors:  J E Turnbull; J T Gallagher
Journal:  Biochem J       Date:  1991-07-15       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.